| Editor's Preface |
|
v | |
| Series Editor's Preface |
|
ix | |
|
|
|
xi | |
|
Comparison of various modes and phase systems for analytical HPLC |
|
|
1 | (72) |
|
|
|
|
|
|
|
|
1 | (7) |
|
Characteristics of HPLC separation |
|
|
1 | (1) |
|
Elution development and chromatographic peaks |
|
|
2 | (1) |
|
Basic characteristics of chromatographic separation |
|
|
3 | (2) |
|
Retention factor and thermodynamic aspects of chromatography |
|
|
5 | (1) |
|
Hydrodynamic (kinetic) aspects of chromatography, band broadening and column efficiency |
|
|
6 | (2) |
|
Chromatographic column and column packing particles |
|
|
8 | (5) |
|
|
|
8 | (2) |
|
Packing materials for HPLC |
|
|
10 | (3) |
|
|
|
13 | (22) |
|
Normal-phase chromatography |
|
|
13 | (1) |
|
Stationary phases and retention mechanism |
|
|
13 | (1) |
|
Retention behaviour in normal-phase chromatography |
|
|
14 | (1) |
|
The mobile phase in normal-phase chromatography |
|
|
15 | (3) |
|
Reversed-phase chromatography |
|
|
18 | (1) |
|
Stationary phases in reversed-phase chromatography |
|
|
19 | (3) |
|
Retention behaviour in reversed-phase chromatography |
|
|
22 | (1) |
|
The mobile phase in reversed-phase chromatography |
|
|
23 | (1) |
|
Retention behaviour of non-ionic solutes in reversed-phase chromatography |
|
|
24 | (2) |
|
Reversed-phase chromatography of ionic compounds |
|
|
26 | (3) |
|
|
|
29 | (2) |
|
|
|
31 | (1) |
|
Ion-exchange chromatography |
|
|
32 | (3) |
|
Method development and optimisation of conditions in isocratic HPLC |
|
|
35 | (14) |
|
Selection of the separation mode |
|
|
35 | (1) |
|
Effects of experimental HPLC conditions on chromatographic resolution |
|
|
36 | (3) |
|
Control of the separation efficiency |
|
|
39 | (1) |
|
Effect of the temperature on separation |
|
|
40 | (1) |
|
Adjustment of the composition of binary mobile phases |
|
|
40 | (1) |
|
Selectivity control using ternary or more complex mobile phases |
|
|
41 | (4) |
|
Computer-assisted optimisation of HPLC methods |
|
|
45 | (4) |
|
Development of gradient-elution separations |
|
|
49 | (20) |
|
Gradient-elution versus other HPLC programming techniques |
|
|
49 | (3) |
|
Theory of HPLC with binary gradients |
|
|
52 | (1) |
|
Gradient elution versus ioscratic elution - effects of the gradient profile on separation |
|
|
53 | (3) |
|
Gradient elution in reversed-phase systems |
|
|
56 | (1) |
|
Gradient elution in normal-phase and ion-exchange systems |
|
|
57 | (1) |
|
Gradient-elution method development |
|
|
58 | (4) |
|
Ternary gradients in HPLC |
|
|
62 | (6) |
|
Sources of errors in prediction of retention in gradient-elution chromatography |
|
|
68 | (1) |
|
|
|
69 | (1) |
|
|
|
69 | (4) |
|
Fast Generic HPLC methods |
|
|
73 | (14) |
|
|
|
|
|
|
|
|
73 | (1) |
|
|
|
74 | (1) |
|
Production of fast gradients |
|
|
74 | (1) |
|
Strategy for production of fast gradients |
|
|
75 | (7) |
|
General strategy for standard bore columns |
|
|
75 | (4) |
|
Production of fast gradients with small bore columns |
|
|
79 | (3) |
|
Fast gradients in practice |
|
|
82 | (3) |
|
|
|
85 | (2) |
|
Application of standard methods in capillary electrophoresis for drug analysis |
|
|
87 | (20) |
|
|
|
|
|
|
Introducton to capillary electrophoresis |
|
|
87 | (2) |
|
Analysis of pharmaceuticals by CE |
|
|
89 | (1) |
|
Low-pH buffer for analysis of basic drugs |
|
|
90 | (2) |
|
High-pH buffer for analysis of acidic drugs |
|
|
92 | (1) |
|
Micellar electrokinetic chromatography (MEKC) for neutral and/or charged drugs |
|
|
93 | (2) |
|
Microemulsion electrokinetic chromatography (MEEKC) for neutral and/or charged drugs |
|
|
95 | (2) |
|
Indirect UV detection method for analysis of inorganic anions |
|
|
97 | (3) |
|
Indirect UV detection method for analysis of simple organic acids |
|
|
100 | (1) |
|
Indirect UV detection method for analysis of metal ions |
|
|
101 | (1) |
|
Non-aqueous CE for analysis of acidic and basic drugs |
|
|
102 | (1) |
|
Benefits of adopting standard CE methods |
|
|
103 | (2) |
|
|
|
105 | (2) |
|
Chapillary electrochromatography (CEC) |
|
|
107 | (20) |
|
|
|
|
|
|
|
|
|
|
|
|
|
107 | (1) |
|
Basic principles of capillary electrochromatography |
|
|
108 | (5) |
|
|
|
108 | (1) |
|
Factors that influence electroendosmotic flow (EOF) |
|
|
109 | (1) |
|
|
|
110 | (2) |
|
|
|
112 | (1) |
|
|
|
113 | (1) |
|
Stationary phases used in CEC |
|
|
113 | (4) |
|
Operational characteristics of CEC |
|
|
117 | (5) |
|
|
|
117 | (1) |
|
|
|
118 | (4) |
|
Gradient and pressure-assisted (pseudo) CEC |
|
|
122 | (1) |
|
|
|
123 | (1) |
|
|
|
123 | (1) |
|
|
|
124 | (3) |
|
Coupled chromatography-mass spectrometry techniques for the analysis of combinatorial libraries |
|
|
127 | (36) |
|
|
|
|
|
|
|
|
127 | (3) |
|
Lc/MS analysis of high-throughout parallel synthesis libraries |
|
|
130 | (10) |
|
Development of walk-up open-access LC/UV/MS systems |
|
|
132 | (2) |
|
|
|
134 | (6) |
|
Example for monitoring the rehearsal phase of the synthesis of a solid-phase library |
|
|
140 | (4) |
|
LC/UV/MS as a pre-screen for autoprep-solution phase |
|
|
144 | (7) |
|
Purity profile for phenyl analogue (Fig 5.14) |
|
|
144 | (1) |
|
Purity profile for carboxy analogue (Fig 5.15) |
|
|
145 | (6) |
|
Purity profile for cyano analogue (Fig. 5.16) |
|
|
151 | (1) |
|
Assisted automated LC/MS analysis |
|
|
151 | (1) |
|
The analysis of split-pool combinatorial libraries |
|
|
152 | (7) |
|
|
|
159 | (1) |
|
|
|
160 | (3) |
|
Optimization strategies for HPLC and CZE |
|
|
163 | (50) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
163 | (2) |
|
Responses and response functions |
|
|
165 | (5) |
|
Univariate optimization strategies |
|
|
170 | (2) |
|
|
|
172 | (25) |
|
|
|
172 | (5) |
|
|
|
177 | (6) |
|
|
|
183 | (1) |
|
Classical symmetrical designs |
|
|
184 | (4) |
|
|
|
188 | (4) |
|
|
|
192 | (5) |
|
|
|
197 | (4) |
|
|
|
201 | (2) |
|
The simplex sequential approach |
|
|
203 | (6) |
|
Automating the whole process: expert systems and knowledge based systems |
|
|
209 | (1) |
|
|
|
210 | (3) |
|
Stragegies for the development of process chromatography as a unit operation for the pharmaceutical industry |
|
|
213 | (80) |
|
|
|
|
|
|
|
|
213 | (4) |
|
The process development cycle |
|
|
217 | (8) |
|
Process discovery, development and implementation |
|
|
217 | (5) |
|
|
|
222 | (3) |
|
Chromatographic unit operations development |
|
|
225 | (1) |
|
Discovery experiment stage |
|
|
225 | (7) |
|
|
|
228 | (1) |
|
|
|
228 | (2) |
|
Column saturation capacity |
|
|
230 | (1) |
|
Relationship between flow rate and plate count |
|
|
231 | (1) |
|
|
|
232 | (11) |
|
Experimental development and modeling |
|
|
233 | (1) |
|
|
|
234 | (1) |
|
|
|
235 | (1) |
|
|
|
236 | (1) |
|
|
|
237 | (1) |
|
Required number of plates |
|
|
237 | (1) |
|
Regeneration and equilibration |
|
|
238 | (1) |
|
|
|
238 | (1) |
|
|
|
238 | (1) |
|
|
|
239 | (1) |
|
Piping, valves and pressure relief |
|
|
239 | (1) |
|
|
|
240 | (1) |
|
Filtration and guard columns |
|
|
240 | (1) |
|
|
|
241 | (1) |
|
|
|
241 | (1) |
|
|
|
241 | (2) |
|
|
|
243 | (32) |
|
|
|
248 | (4) |
|
|
|
252 | (3) |
|
Column saturation capacity |
|
|
255 | (4) |
|
|
|
259 | (2) |
|
|
|
261 | (2) |
|
|
|
263 | (4) |
|
|
|
267 | (1) |
|
Solvent costs ($/g) |
|
|
267 | (5) |
|
|
|
272 | (1) |
|
|
|
273 | (2) |
|
|
|
275 | (7) |
|
Regulatorya and compliance |
|
|
282 | (6) |
|
|
|
284 | (1) |
|
|
|
285 | (1) |
|
Composition of mobile phase, regeneration solution and local solution |
|
|
285 | (1) |
|
|
|
286 | (1) |
|
Load concentration or volume |
|
|
287 | (1) |
|
Cut point location strategy |
|
|
287 | (1) |
|
|
|
288 | (1) |
|
|
|
289 | (1) |
|
|
|
289 | (4) |
|
The development and industrial application of automated preparative HPLC |
|
|
293 | (44) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
293 | (3) |
|
Instrumental considerations |
|
|
296 | (3) |
|
|
|
296 | (1) |
|
Stationary phase selection |
|
|
297 | (2) |
|
Operating principles and gradient details |
|
|
299 | (1) |
|
|
|
300 | (11) |
|
Analytical scale investigation |
|
|
300 | (1) |
|
Preparative scale-up and sample introduction considerations |
|
|
301 | (2) |
|
Validation of the preparative chromatography |
|
|
303 | (6) |
|
The autoprep purification |
|
|
309 | (2) |
|
Practical considerations and `calibrated' methods |
|
|
311 | (16) |
|
Problems with the initial generic approach |
|
|
311 | (4) |
|
The `calibrated' method for hydrophilic compounds |
|
|
315 | (5) |
|
`Calibrated' methods and the advantages of their application |
|
|
320 | (7) |
|
Additional system developments |
|
|
327 | (2) |
|
|
|
329 | (6) |
|
The addition of a mass spectrometer |
|
|
329 | (1) |
|
Mass spectrometer considerations and chromatography adjustments |
|
|
330 | (2) |
|
Instrumental layout and software demands |
|
|
332 | (1) |
|
MS-prep system refinements |
|
|
333 | (2) |
|
|
|
335 | (1) |
|
|
|
336 | (1) |
|
|
|
336 | (1) |
|
Recent developments in liquid chromatographic enantioseparation |
|
|
337 | (102) |
|
|
|
|
|
|
|
|
|
|
|
|
|
337 | (11) |
|
Impact of stereochemistry on drug development |
|
|
337 | (1) |
|
Historical background of modern liquid-phase enantioseparation |
|
|
338 | (1) |
|
Scope and aims of this chapter |
|
|
339 | (1) |
|
Mechanism of chiral recognition and enantioseparation |
|
|
339 | (9) |
|
Direct enantioseparation by liquid chromatography with chiral stationary phases (CSPs) - chiral selectors and chiral recognition mechanisms |
|
|
348 | (71) |
|
Polymeric type selectors and chiral stationary phases |
|
|
350 | (1) |
|
Polymeric type CSPs primarily operated in the non-aqueous mobile phase mode |
|
|
350 | (15) |
|
Protein type CSPs - representing a class of polymeric type CSPs which can be used with aqueous mobile phases |
|
|
365 | (8) |
|
CSPs with macrocyclic, oligomeric and/or intermediate molecular size selectors |
|
|
373 | (1) |
|
|
|
373 | (8) |
|
CSPs with macrocyclic glycopeptide antibiotics as selectors |
|
|
381 | (11) |
|
|
|
392 | (3) |
|
Low molecular weight selectors |
|
|
395 | (1) |
|
CSPs based on chiral selectors related to the Pirkle concept |
|
|
395 | (10) |
|
|
|
405 | (9) |
|
Ligand-exchange type CSPs |
|
|
414 | (4) |
|
|
|
418 | (1) |
|
Some aspects of preparative enantioseparation methods |
|
|
419 | (3) |
|
Other enantioselecgtive liquid-phase separation techniques |
|
|
422 | (3) |
|
|
|
425 | (1) |
|
Addendum to literature - books on chiral discrimination |
|
|
425 | (1) |
|
|
|
426 | (13) |
|
Basis and pharmaceutical applications of thin-layer chromatography |
|
|
439 | (64) |
|
|
|
|
|
|
|
|
|
|
|
|
|
439 | (9) |
|
|
|
440 | (1) |
|
|
|
441 | (1) |
|
Advantages of planar chromatography |
|
|
442 | (1) |
|
|
|
443 | (2) |
|
Elution, frontal and displacement modes |
|
|
445 | (1) |
|
Planar vs. column chromatography |
|
|
446 | (1) |
|
Advances in thin-layer chromatography |
|
|
447 | (1) |
|
Multidimensional planar chromatography |
|
|
448 | (1) |
|
The components of the planar stationary phase |
|
|
448 | (8) |
|
Stationary phases for chromatography |
|
|
448 | (1) |
|
|
|
448 | (2) |
|
Inert stationary phase containing silicium dioxides |
|
|
450 | (1) |
|
|
|
450 | (1) |
|
Magnesia (magnesium oxide, magnesium hydroxide) |
|
|
451 | (1) |
|
|
|
451 | (1) |
|
|
|
451 | (1) |
|
Sephadex and BioGel P gels |
|
|
452 | (1) |
|
Chemically modified stationary phases |
|
|
452 | (1) |
|
|
|
453 | (1) |
|
Methods and stationary phases for enantiomeric separations |
|
|
453 | (1) |
|
|
|
454 | (1) |
|
Special additives to the stationary phase |
|
|
454 | (1) |
|
|
|
454 | (1) |
|
|
|
455 | (1) |
|
|
|
455 | (1) |
|
Mobile phases for thin-layer chromatography |
|
|
456 | (2) |
|
Optimisation of solvent systems |
|
|
457 | (1) |
|
|
|
458 | (6) |
|
|
|
458 | (1) |
|
Chambers in instrumental TLC |
|
|
459 | (1) |
|
Centrifugal thin-layer chromatography |
|
|
459 | (1) |
|
High-speed thin-layer chromatography |
|
|
459 | (1) |
|
Automated multiple development (AMD) |
|
|
459 | (1) |
|
Forced-flow thin-layer chromatography (FF-TLC) |
|
|
460 | (4) |
|
|
|
464 | (7) |
|
|
|
464 | (1) |
|
Non-destructive detections |
|
|
465 | (2) |
|
Detection of TLC with on-line coupled spectroscopic methods other than UV and/or visible monitoring |
|
|
467 | (1) |
|
HPTLC-FTIR on-line coupling |
|
|
467 | (1) |
|
|
|
468 | (1) |
|
|
|
469 | (1) |
|
|
|
469 | (1) |
|
Electrochemical detection |
|
|
469 | (1) |
|
|
|
470 | (1) |
|
|
|
470 | (1) |
|
Flame-ionisation detector (FID) |
|
|
471 | (1) |
|
Application of TLC in pharmaceutical and forensic analysis |
|
|
471 | (23) |
|
Analysis of drugs and metabolities |
|
|
471 | (21) |
|
Application of TLC in the study of lipophilicity |
|
|
492 | (2) |
|
Quo vadis thin-layer chromatography |
|
|
494 | (4) |
|
|
|
498 | (1) |
|
|
|
498 | (5) |
|
Recent advances in quantitative structure-retention relationships (QSRR) |
|
|
503 | (32) |
|
|
|
|
|
|
|
|
503 | (2) |
|
Strategy of QSRR research |
|
|
505 | (8) |
|
|
|
506 | (3) |
|
|
|
509 | (2) |
|
Structural descriptors for QSRR |
|
|
511 | (2) |
|
|
|
513 | (5) |
|
Molecular mechanisms of retention in view of QSRR |
|
|
518 | (4) |
|
Chromatographic methods of determination of hydrophobicity |
|
|
522 | (2) |
|
Applications of QSRR in molecular pharmacology and rational drug design |
|
|
524 | (5) |
|
|
|
529 | (1) |
|
|
|
530 | (5) |
|
Measurements of physical properties for drug design in industry |
|
|
535 | (50) |
|
|
|
|
|
|
|
|
535 | (1) |
|
Measurements of compound lipophilicity using chromatography |
|
|
536 | (13) |
|
Measurements of liquid-liquid partition |
|
|
536 | (6) |
|
Measurements of chromatographic partition |
|
|
542 | (1) |
|
Application of gas chromatography |
|
|
542 | (1) |
|
Applicationof thin-layer chromatography (TLC) |
|
|
543 | (1) |
|
Application of reversed-phase high-performance liquid chromatography (RP-HPLC) |
|
|
543 | (6) |
|
Measuremenrts of members transport by immobilised artificial membrane (IAM) HPLC |
|
|
549 | (3) |
|
Measurements of drug-protein binding constants using chromatography |
|
|
552 | (5) |
|
Measurements of solubility by HPLC |
|
|
557 | (2) |
|
Concentration determination by HPLC for solubility measurements |
|
|
557 | (1) |
|
Partition coefficient determination for solubility estimation |
|
|
558 | (1) |
|
Measurements of acid-base character (pKa) by HPLC |
|
|
559 | (5) |
|
pH dependence of lipophilicity and solubility |
|
|
559 | (2) |
|
pH dependence of chromatographic retention |
|
|
561 | (1) |
|
Estimation of lipophility of pKa by gradient reversed-phase chromatography |
|
|
562 | (2) |
|
Measurements of H-bond acidity, and polarisability-dipolarity by HPLC |
|
|
564 | (16) |
|
The importance of H-bond acidity, basicity and polarisability-dipolarity in describing various partition processes and solubility |
|
|
564 | (1) |
|
Description of various lipophilicity scales by molecular descriptors (solvation equations) |
|
|
564 | (3) |
|
Description of various chromatographic lipophilicity scales by the molecular descriptors |
|
|
567 | (1) |
|
Description of solubility by the molecular descriptors |
|
|
568 | (1) |
|
Determination of molecular descriptors by chromatography |
|
|
569 | (11) |
|
|
|
580 | (1) |
|
|
|
580 | (5) |
| Subject Index |
|
585 | |